Home > Items where Subject is "B Substances > New (novel) psychoactive substances > Indolalkylamines (tryptamines) / Phenethylamines"

up arrow imageUp a level
Export as
Group by: Item Type | No Grouping
Jump to: Article | Report | Webpage
Number of items at this level: 12.

Article

Uthaug, Malin Vedøy and Davis, Alan K and Haas, Trevor Forrest and Davis, Dawn and Dolan, Sean B and Lancelotta, Rafael and Timmermann, Christopher and Ramaekers, Johannes G (2022) The epidemiology of mescaline use: pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects. Journal of Psychopharmacology , 36 , (3) , pp. 309-320.

Fattore, Liana and Marti, Matteo and Mostallino, Rafaela and Castelli, Maria Paola (2020) Sex and gender differences in the effects of novel psychoactive substances. Brain Sciences , 10 , (9) .

Galvin, Brian (2013) Annual review of the drug situation in Europe. Drugnet Ireland , Issue 46, Summer 2013 , pp. 5-6.

Report

United Nations Office on Drugs and Crime. (2024) The challenge of new psychoactive substances - a technical update. Vienna: United Nations.

WHO Expert Committee on Drug Dependence. (2017) 39th Expert Committee on Drug Dependence: technical documents. Geneva: World Health Organization.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Report on the risk assessment of 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine in the framework of the Council Decision on new psychoactive substances. Luxembourg: Office for Official Publications of the European Communities.

Europol, European Monitoring Centre for Drugs and Drug Addiction. (2014) EMCDDA–Europol joint report on a new psychoactive substance: 25I-NBOMe. (4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine). Lisbon: European Monitoring Centre for Drugs and Drug Addiction & Europol.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Report on the risk assessment of 4-methylamphetamine in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union.

Laboratory and Scientific Section, United Nations Office on Drugs and Crime. (2013) The challenge of new psychoactive substances. A report from the Global SMART Programme. Vienna: United Nations Office on Drugs and Crime.

European Monitoring Centre for Drugs and Drug Addiction. (2004) Report on the risk assessment of 2C-I, 2C-T-2 and 2C-T-7 in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.

European Monitoring Centre for Drugs and Drug Addiction. (1999) Report on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.

Webpage

United Nations Office on Drugs and Crime. (2023) UNODC Early warning advisory (EWA) on new psychoactive substances (NPS). URL: https://www.unodc.org/LSS/Home/NPS

This list was generated on Sun Jul 14 04:44:08 2024 IST.